Access for All
Access for All
At Medidata, we are committed to ensuring that all patients have access to treatment by breaking barriers and challenging norms in order to improve access to comprehensive, quality services. With a concentration in diversity in clinical trials, drug repurposing, and patient advocacy we are creating a better world for patients.
Drug Repurposing
Through our partnership with Cures Within Reach and the Castleman Disease Collaborative Network, Medidata is a strong supporter of finding cost effective solutions for patients. We believe that drug repurposing will help the thousands of patients that are impacted by rare diseases. From our partnerships in our Social Innovation Lab to our products such as Rave Omics software, we are making an impact for patients.
Patient Advocacy
Patient’s are at the core of our mission which is why we partner with patient advocacy organizations across the globe. Our relationships with the American Heart Association, American Cancer Society, Leukemia & Lymphoma Society amongst many others help us drive our impact and incorporate our patients into our strategy. In 2019, we are launching a Patient Advocacy Steering committee to further integrate the patient into our business.